News

Northway Biotech Enters Manufacturing Agreement With Kaida BioPharma for Lead Oncology Program KAD101
Leveraging Northway Biotech’s 20+ years of CDMO expertise, Kaida BioPharma is advancing KAD101, a targeted therapy for ...
The Manila Times57m
China's Aphranel MagiCCrystal CaHA Filler Debuts Globally, Ushering in a New Era of Regenerative Aesthetic Medicine
On , Shanghai Moyom Biotechnology Co., Ltd. unveiled its breakthrough regenerative aesthetic innovation, Aphranel ...
The Manila Times54m
Kaida BioPharma Announces New Partnership with Northway Biotech for the Manufacturing of KAD101
"We are proud to partner with Kaida BioPharma on the development of KAD101,” said Prof. Vladas Algirdas Bumelis, CEO and ...